go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Kansas rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $3,981 · 10th–90th $2,089$4,8980%50%10th90th$3,981Professionalmedian $3,162 · 10th–90th $2,089$4,1690%20%40%10th90th$3,162$1.0K$2.0K$5.0K$10.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,511.89
Median
$3,981.07
Typical High
$4,168.69
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,089.30
Median
$2,290.87
Typical High
$4,168.69
Cigna
Setting
Facility
Modifier
Global
Typical Low
$4,365.16
Median
$4,897.79
Typical High
$5,754.40
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Medica
Setting
Facility
Modifier
Global
Typical Low
$794.33
Median
$3,981.07
Typical High
$4,168.69
Medica
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$23,988.33
United
Setting
Facility
Modifier
Global
Typical Low
$3,467.37
Median
$3,467.37
Typical High
$4,073.80
United
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$4,677.35